<DOC>
	<DOCNO>NCT01259102</DOCNO>
	<brief_summary>The purpose study determine pharmacokinetics BTDS follow same-site patch reapplication rest interval .</brief_summary>
	<brief_title>Examine Plasma Concentrations Buprenorphine Following Reapplication Buprenorphine Transdermal System ( BTDS ) After Variable Application Site Rest Periods</brief_title>
	<detailed_description>The purpose study determine minimum application site rest period ensure reapplication BTDS 10 site deltoid region result increase absorption drug normal healthy subject .</detailed_description>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Inclusion Criteria Include : Males females 18 45 year age , inclusive . Weight 60 100 kilogram ( kg ) [ 132220 pound ( lb ) ] within 15 % optimum height body frame . In good health , evidence lack significantly abnormal finding medical history , physical examination , clinical laboratory test , vital sign , electrocardiogram ( ECG ) . Willing discontinue abstain medication , include vitamin mineral supplement , throughout study . Willing follow dietary restriction , include abstention caffeine xanthinecontaining beverage duration study . Did smoke chew tobacco least 45 day prior administration study drug , agree use tobacco product study Exclusion Criteria Include : A history hypersensitivity opioid psychotropic drug . A history recurrent seizures syncope . Any medical surgical condition might interfere transdermal absorption , distribution , metabolism , excretion drug . Any significant active medical illness : history presence liver disease liver injury indicate abnormal liver function profile aspartate transaminase ( AST ) , alanine transaminase ( ALT ) , serum bilirubin ; history presence impair renal function indicate abnormal creatinine blood urea nitrogen ( BUN ) value abnormal urinary constituent ( eg , albuminuria ) ; history neutropenia ( absolute neutrophil count [ ANC ] &lt; 1000/mm3 thrombocytopenia ( platelet &lt; 150,000/mm3 ) . Positive result urine drug screen urine cotinine ( consistent active smoking ) . A history substance alcohol abuse within past 5 year . Females nurse . Females pregnant confirm positive serum human chorionic gonadotropin ( bHCG ) test . Other protocolspecific exclusion/inclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Healthy subject</keyword>
	<keyword>Opioid</keyword>
	<keyword>Transdermal</keyword>
</DOC>